Specialized in capital sales, software, & disposables for advanced Targeted Temperature Management across Neurocritical Care, Cardiac, Surgical, Medical, Pediatric, & Neonatal Critical Care, E.R., C-suite, & Administration. Grew customer base to (81) accounts & standardized over 90% of regional health systems to Arctic Sun. Annual Sales Growth:•2023 -Ranked #2 in Nation. Exceeded capital quota for 10th year and disposable quota for 9th year during 11-year tenure. Achieved 158.72% to capital & 112.5% to disposables. Sold $2,305,368 in capital & $4,127,079 in disposables.•2021 -Ranked #3 in Nation. Sold $3,780,141 in disposables to 106% & $1,513,757 in capital to 159.34%. Exceeded capital quota for 9th year & disposable quota for 8th year. •2019 -Ranked #2 in Nation. Sold $3,309,644 in disposables to 120.5% & $1,858,145 in Capital to 194%. •2018 -Exceeded capital quota for 6th year in a row.•2017 -Ranked #2 in Nation. Exceeded quota for Capital to 120% to plan at $1,011,824 & Disposables to 106.7% at $2,726,096.•2016 -Ranked #4 in Nation. Exceeded quota for Capital by 139.52% & Disposables by 104.63%. Sold $1,074,286 in Capital & sold $2,332,200 in Disposables.•2015 -Ranked #1 in Nation for 2nd year in a row. Exceeded Capital quota by 166% & Disposables by 128.3%. Grew Total Territory by 30.39% to $3,582,796, following top-ranked performance in 2014. Grew Capital sales by 40.84% to $1,546,817. Grew Disposable sales by 23.43% to $2,035,979. •2014 -Ranked #1 in Nation. Exceeded quota for Capital to 190% & Disposables to 113%. Grew Total Territory sales by 54.73% to $2,747,711. Grew Capital by 99.37% to $1,098,258. Grew Disposables by 34.66% to $1,649,453. •2013 -Exceeded Capital Quota to104.3% & 108% to for Disposables. Grew Capital by 68.98% to $550,877. Prior year sales before starting in territory: $326,000. Grew Total Territory by 36.33% to $1,775,780. Grew Disposables by 25.43% to $1,224,903. Prior year sales, before starting in territory: $976,545.

Specialized in the direct sales and service of spinal implants and surgical instrumentation. Represented Zimmer Spine, Osteomed Spine and Centinel Spine. • Hired back to sell spinal implants, surgical instrumentation and biologics to neurosurgeons and orthopedic spine surgeons. • Provided technical assistance to surgeons and hospital staff during spinal fusion procedures.• Trained and managed junior sales representatives and clinical assistants.• Negotiated new product approvals and contract pricing to hospitals.Annual Sales Growth and Accomplishments:• 2012 - Ranked in the top 7% of the Nation, while ranking 12th out of 160 sales representatives.• 2010 - Trained and managed new sales representatives and clinical assistants while integrating additional product lines and growing territory sales from $2,927,119 in 2009 to $3,259,978 in 2010.• 2009 - Selected by management to train new reps and clinical assistants.• 2008 - Grew territory sales by 87.8% to $1,564,015.• 2007 - Dramatically increased territory sales by 998% in just one year, from $75,770 to $756,728.• 2006 - Grew territory sales from zero to $75,770 in rookie year, in expansion territory.

Specialized in the direct sales and service of Medtronic peripheral vascular products to interventional cardiologists, vascular surgeons, interventional radiologists and lab staff.• 2005 - Earned Sales Blitz Contest, 2nd Fiscal Quarter: National Peripheral Sales Award

• Specialized in the direct sales and service of spinal implants, surgical instrumentation and biologics to neurosurgeons and orthopedic spine surgeons. • Provided technical assistance to surgeons and hospital staff during spinal fusion procedures.• Negotiated new product approvals and contract pricing to hospitals.Annual Sales Growth and Accomplishments:• 2003 - Earned Eastern Area Sales Growth Award: 55% sales growth from prior year.• 2002 - President’s Club Award Winner, National Sales Performance Award.• 2002 - Grew territory sales by 48.98% to $1,316,240. Prior year sales were $883,462.• 2002 - Summit Club Award Winner: Quota Achievement Award.• 2002 - Pinnacle Club Award Winner, 1st Half 2002 Quota Achievement.• 2002 - Interbody Fusion Sales Award, 2002: Achieved #1 ranking in the Atlantic Area, 1st Half 2002: Spinal Column Company Sales Ranking for percent to quota achievement. • 2001 - Ranked #2 out of 59 representatives for total sales performance, year-end 2001. Rating based on percent-to-quota achievement: Spinal Column Company Sales Ranking.• 2001 - Sales Representative Rookie of the Year: National Sales Performance Award. • 2001 - Grew annual territory sales to $883,462. Prior year sales were $318,057. • 2001 - Increased sales by 177%.• 2001 - Summit Club Award Winner: Quota Achievement Award.• 2001 - BP Sales Contest Award Winner: National Sales Performance Award.• 2001 - Outstanding Sales Performance Award: Cervical Fusion Quota Achievement, 2nd Half.• 2001 - Outstanding Sales Performance Award: Proceed Quota Achievement, 1st Half.• 2001 - Outstanding Sales Performance Award: Total Sales Quota Achievement, 1st Half.

• Specialized in the direct sales and education of pharmaceutical medications for primary-open angle glaucoma and ocular hypertension to ophthalmologists.• Overcame managed care restrictions by gaining formulary access and clinical support for Merck’s ophthalmic medications.Annual Sales Growth and Accomplishments:• 2000 - Ranked within the top (10) out of (75) ophthalmic specialists across the nation for total sales performance through June. • 2000 - Earned Certificate of Achievement for completing the Sales Class Counselor Training & Certification Program, March 2000. Served as a sales class counselor for the 1999 and 2000 Ophthalmic Training departments, and mentored new district representatives. • 1999 - Grew territory sales at a rate higher than the National and District growth rates; with year-ending sales of $3.6 million and a territory growth rate of 6.1% (versus the nation at 2.7%) over prior year sales. Two-year sales growth average for territory is 10% versus the national average of 2.95%.• 1999 - Ranked in the top 10% of the total Ophthalmic Specialty Sales Force across the nation, out of (75) reps. • 1999 - Earned two District Cosopt Crusader Awards for outstanding market share growth, September and November 1999. Year-end territory market share performance for primary product, Cosopt, was 8.0% (above the nation at 5.8% and the Northeast II district at 7.6%). • 1998 - Grew territory sales at a rate higher than the National and District growth rates; with year-ending sales of $3.371 million and a territory growth rate of 14% (versus the nation at 3.2%) over prior year sales.• 1998 - Earned Award for Excellence: National market share performance award for Trusopt.